Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine

Preferred Label : Autologous Lymphoma Cell/Autologous Dendritic Cell Electrofusion Hybrid Vaccine;

NCIt definition : A cell-based cancer vaccine consisting of hybrid cells created by electrofusing autologous dendritic cells (DCs) and autologous lymphoma cells with potential immunostimulating and antitumor activities. Upon administration, autologous lymphoma cell/autologous dendritic cell electrofusion hybrid vaccine may stimulate the immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against specific autologous lymphoma-associated antigens, resulting in lymphoma cell apoptosis.;

NCI Metathesaurus CUI : CL412319;

Details

Origin ID

C85450;

UMLS CUI

C2827673;

Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients